Insider · CIK 0002025621
Matthew Shields
Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing Jun 5, 2025, latest Jun 22, 2026.
In brief
Matthew Shields files SEC Form 4 as officer at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). Since Jun 5, 2025, Matthew Shields has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.5M, the latest filed on Jun 22, 2026.
A track record needs three past buys with six months of prices behind them; Matthew Shields has 0, so none is measured yet.
The newest scored trade: sold $322k of TEVA on Jun 18, 2026, filed Jun 22, 2026, scored 64 (notable). In the last 12 months: 0 buys worth $0 and 3 sells worth $1.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | TEVA PHARMACEUTICAL INDUSTRIES LTD | $322k 9,989 shares | -100% | +105% from low-13% from high | |
| 33Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $532k 16,195 shares | -62% | +113% from low-10% from high | |
| 34Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $548k 17,295 shares | -63% | +148% from low-12% from high | |
| 28Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $106k 6,206 shares | -38% | +34% from low-25% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 18, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,989 0.00% of outstanding | $322k | Jun 18, 2026 | $532k |
| Jun 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 16,195 0.00% of outstanding | $532k | Jun 3, 2026 | $548k |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 17,295 0.00% of outstanding | $548k | Mar 5, 2026 | none |
| Jun 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 6,206 0.00% of outstanding | $106k | Jun 3, 2025 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares | -9,989 | $32.19 | $322k | 0 | Jun 22, 2026 |
| Jun 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +16,195 | - | - | 26,184 | Jun 4, 2026 |
| Jun 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -16,195 | $32.87 | $532k | 9,989 | Jun 4, 2026 |
| Jun 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -16,195 | $0.00 | $0 | 32,392 | Jun 4, 2026 |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +17,295 | - | - | 27,284 | Mar 9, 2026 |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -17,295 | $31.67 | $548k | 9,989 | Mar 9, 2026 |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -17,295 | $0.00 | $0 | 51,887 | Mar 9, 2026 |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative | +33,424 | $0.00 | $0 | 33,424 | Mar 6, 2026 |
| Jun 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares | +16,195 | - | - | 16,195 | Jun 5, 2025 |
| Jun 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares | -6,206 | $17.02 | $106k | 9,989 | Jun 5, 2025 |
| Jun 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative | -16,195 | $0.00 | $0 | 48,587 | Jun 5, 2025 |
Questions about Matthew Shields
Answered from the filings on this page, as of the latest one.
Is Matthew Shields buying or selling?
In the last 12 months Matthew Shields reported 0 open-market buys worth $0 and 3 open-market sells worth $1.4M on SEC Form 4; the latest was sold $322k of TEVA on Jun 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Matthew Shields's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Shields has 0.
Where does Matthew Shields file Form 4?
Matthew Shields has filed Form 4 at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD) as EVP, Global Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.